BCL2 and cancer: Various mechanisms are considered to cause the anti‐cancer action of Cetuximab, involving the direct blockage of EGFR tyrosine kinase, restricting cell cycle, raising the quantity and activity of the cell death‐inducing molecule, such as Bcl‐2 and Bax, and increasing radiotherapy and chemotherapy anti‐cancer effects.41